Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

Long interspersed nucleotide element 1 hypomethylation is associated with poor prognosis of lung adenocarcinoma.

Ikeda K, Shiraishi K, Eguchi A, Shibata H, Yoshimoto K, Mori T, Baba Y, Baba H, Suzuki M.

Ann Thorac Surg. 2013 Nov;96(5):1790-4. doi: 10.1016/j.athoracsur.2013.06.035. Epub 2013 Aug 30.

PMID:
23998411
2.

Long interspersed nuclear element 1 hypomethylation is a marker of poor prognosis in stage IA non-small cell lung cancer.

Saito K, Kawakami K, Matsumoto I, Oda M, Watanabe G, Minamoto T.

Clin Cancer Res. 2010 Apr 15;16(8):2418-26. doi: 10.1158/1078-0432.CCR-09-2819. Epub 2010 Apr 6.

3.

LINE-1 hypomethylation is associated with a poor prognosis among patients with curatively resected esophageal squamous cell carcinoma.

Iwagami S, Baba Y, Watanabe M, Shigaki H, Miyake K, Ishimoto T, Iwatsuki M, Sakamaki K, Ohashi Y, Baba H.

Ann Surg. 2013 Mar;257(3):449-55. doi: 10.1097/SLA.0b013e31826d8602.

PMID:
23023202
4.

LINE-1 hypomethylation in gastric cancer, detected by bisulfite pyrosequencing, is associated with poor prognosis.

Shigaki H, Baba Y, Watanabe M, Murata A, Iwagami S, Miyake K, Ishimoto T, Iwatsuki M, Baba H.

Gastric Cancer. 2013 Oct;16(4):480-7. doi: 10.1007/s10120-012-0209-7. Epub 2012 Nov 21.

5.

Aberrant methylation of LINE-1, SLIT2, MAL and IGFBP7 in non-small cell lung cancer.

Suzuki M, Shiraishi K, Eguchi A, Ikeda K, Mori T, Yoshimoto K, Ohba Y, Yamada T, Ito T, Baba Y, Baba H.

Oncol Rep. 2013 Apr;29(4):1308-14. doi: 10.3892/or.2013.2266. Epub 2013 Jan 31.

6.
7.

Prognostic significance of promoter CpG island hypermethylation and repetitive DNA hypomethylation in stage I lung adenocarcinoma.

Rhee YY, Lee TH, Song YS, Wen X, Kim H, Jheon S, Lee CT, Kim J, Cho NY, Chung JH, Kang GH.

Virchows Arch. 2015 Jun;466(6):675-83. doi: 10.1007/s00428-015-1749-0. Epub 2015 Mar 13.

PMID:
25772390
8.

LINE-1 hypomethylation in noncancerous esophageal mucosae is associated with smoking history.

Shigaki H, Baba Y, Watanabe M, Iwagami S, Miyake K, Ishimoto T, Iwatsuki M, Baba H.

Ann Surg Oncol. 2012 Dec;19(13):4238-43. doi: 10.1245/s10434-012-2488-y. Epub 2012 Jul 6.

PMID:
22766991
9.

Pyrosequencing assay to measure LINE-1 methylation level in esophageal squamous cell carcinoma.

Iwagami S, Baba Y, Watanabe M, Shigaki H, Miyake K, Ida S, Nagai Y, Ishimoto T, Iwatsuki M, Sakamoto Y, Miyamoto Y, Baba H.

Ann Surg Oncol. 2012 Aug;19(8):2726-32. doi: 10.1245/s10434-011-2176-3. Epub 2011 Dec 21.

PMID:
22187122
10.

LINE-1 hypomethylation, DNA copy number alterations, and CDK6 amplification in esophageal squamous cell carcinoma.

Baba Y, Watanabe M, Murata A, Shigaki H, Miyake K, Ishimoto T, Iwatsuki M, Iwagami S, Yoshida N, Oki E, Sakamaki K, Nakao M, Baba H.

Clin Cancer Res. 2014 Mar 1;20(5):1114-24. doi: 10.1158/1078-0432.CCR-13-1645. Epub 2014 Jan 14.

11.

LINE-1 hypomethylation is associated to specific clinico-pathological features in Stage I non-small cell lung cancer.

Imperatori A, Sahnane N, Rotolo N, Franzi F, Nardecchia E, Libera L, Romualdi C, Cattoni M, Sessa F, Dominioni L, Furlan D.

Lung Cancer. 2017 Jun;108:83-89. doi: 10.1016/j.lungcan.2017.03.003. Epub 2017 Mar 6.

PMID:
28625654
12.

LINE-1 hypomethylation level as a potential prognostic factor for epithelial ovarian cancer.

Pattamadilok J, Huapai N, Rattanatanyong P, Vasurattana A, Triratanachat S, Tresukosol D, Mutirangura A.

Int J Gynecol Cancer. 2008 Jul-Aug;18(4):711-7. Epub 2007 Oct 18.

PMID:
17944913
13.

High frequency of alterations in DNA methylation in adenocarcinoma of the prostate.

Santourlidis S, Florl A, Ackermann R, Wirtz HC, Schulz WA.

Prostate. 1999 May 15;39(3):166-74.

PMID:
10334105
14.

Long interspersed nuclear element-1 hypomethylation is a potential biomarker for the prediction of response to oral fluoropyrimidines in microsatellite stable and CpG island methylator phenotype-negative colorectal cancer.

Kawakami K, Matsunoki A, Kaneko M, Saito K, Watanabe G, Minamoto T.

Cancer Sci. 2011 Jan;102(1):166-74. doi: 10.1111/j.1349-7006.2010.01776.x. Epub 2010 Nov 19.

15.

Prognostic relevance of aberrant DNA methylation in g1 and g2 pancreatic neuroendocrine tumors.

Stefanoli M, La Rosa S, Sahnane N, Romualdi C, Pastorino R, Marando A, Capella C, Sessa F, Furlan D.

Neuroendocrinology. 2014;100(1):26-34. doi: 10.1159/000365449. Epub 2014 Jul 5.

PMID:
25011998
16.

LINE-1 methylation level and prognosis in pancreas cancer: pyrosequencing technology and literature review.

Yamamura K, Kosumi K, Baba Y, Harada K, Gao F, Zhang X, Zhou L, Kitano Y, Arima K, Kaida T, Takeyama H, Higashi T, Imai K, Hashimoto D, Chikamoto A, Tan X, Baba H.

Surg Today. 2017 Dec;47(12):1450-1459. doi: 10.1007/s00595-017-1539-1. Epub 2017 May 23. Review.

PMID:
28536860
17.

A cohort study of tumoral LINE-1 hypomethylation and prognosis in colon cancer.

Ogino S, Nosho K, Kirkner GJ, Kawasaki T, Chan AT, Schernhammer ES, Giovannucci EL, Fuchs CS.

J Natl Cancer Inst. 2008 Dec 3;100(23):1734-8. doi: 10.1093/jnci/djn359. Epub 2008 Nov 25.

18.

Evaluation of serum LINE-1 hypomethylation as a prognostic marker for hepatocellular carcinoma.

Ramzy II, Omran DA, Hamad O, Shaker O, Abboud A.

Arab J Gastroenterol. 2011 Sep;12(3):139-42. doi: 10.1016/j.ajg.2011.07.002. Epub 2011 Aug 20.

PMID:
22055592
19.

Prognostic significance of LINE-1 hypomethylation in oropharyngeal squamous cell carcinoma.

Furlan C, Polesel J, Barzan L, Franchin G, Sulfaro S, Romeo S, Colizzi F, Rizzo A, Baggio V, Giacomarra V, Dei Tos AP, Boscolo-Rizzo P, Vaccher E, Dolcetti R, Sigalotti L, Fratta E.

Clin Epigenetics. 2017 May 30;9:58. doi: 10.1186/s13148-017-0357-z. eCollection 2017.

20.

Hypomethylation of retrotransposable elements correlates with genomic instability in non-small cell lung cancer.

Daskalos A, Nikolaidis G, Xinarianos G, Savvari P, Cassidy A, Zakopoulou R, Kotsinas A, Gorgoulis V, Field JK, Liloglou T.

Int J Cancer. 2009 Jan 1;124(1):81-7. doi: 10.1002/ijc.23849.

Supplemental Content

Support Center